
|Videos|September 15, 2015
Will There Be Hesitancy to Prescribe Biosimilars?
Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.
Advertisement
Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.
This video was recorded at the 2015 NACDS Total Store Expo.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
3
Long Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
4
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
5

















































































































































































































